Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Reproductive Sciences
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lurie, S.
Right arrow Articles by Bar, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lurie, S.
Right arrow Articles by Sadan, O.
Right arrow Articles by Oron, G.
Right arrow Articles by Fux, A.
Right arrow Articles by Boaz, M.
Right arrow Articles by Ezri, T.
Right arrow Articles by Golan, A.
Right arrow Articles by Bar, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Reduced Pseudocholinesterase Activity in Patients With HELLP Syndrome

Samuel Lurie, MD

Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel, lurie{at}nashim.net, drslurie{at}hotmail.com, Sackler School of Medicine,Tel Aviv University, Tel Aviv, Israel

Oscar Sadan, MD

Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel, Sackler School of Medicine,Tel Aviv University, Tel Aviv, Israel

Galia Oron, MD

Perinatal Division, Department of Obstetrics and Gynecology, Rabin Medical Center Beilinson Campus, Petah Tiqva, Israel, Sackler School of Medicine,Tel Aviv University, Tel Aviv, Israel

Asora Fux, PhD

Department of Biochemistry, Edith Wolfson Medical Center, Holon, Israel

Mona Boaz, PhD

Epidemiology and Statistics Unit, Edith Wolfson Medcial Center, Holon, Israel, Sackler School of Medicine,Tel Aviv University, Tel Aviv, Israel

Tiberiu Ezri, MD

Department of Anesthesia, Edith Wolfson Medical Center, Holon, Israel, Sackler School of Medicine,Tel Aviv University, Tel Aviv, Israel

Abraham Golan, MD, FRCOG

Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel, Sackler School of Medicine,Tel Aviv University, Tel Aviv, Israel

Jacob Bar, MD

Perinatal Division, Department of Obstetrics and Gynecology, Rabin Medical Center Beilinson Campus, Petah Tiqva, Israel, Sackler School of Medicine,Tel Aviv University, Tel Aviv, Israel

The authors previously reported a case of decreased pseudocholinesterase activity in a patient with HELLP syndrome. It was assumed that the reduced pseudocholinesterase activity in HELLP syndrome is associated with impaired liver function. The present study assesses the prevalence of low pseudocholinesterase in patients with HELLP syndrome. Serum pseudocholinesterase activity was determined with spectrophotometer in 15 patients with HELLP syndrome. Two control groups matched for gestational age were recruited: 15 healthy women with uncomplicated pregnancy and 15 women with severe preeclampsia without HELLP. The prevalence of reduced pseudocholinesterase activity lower than normal limit was 60.0% (9/15) in patients with HELLP syndrome, 33.3% (5/15) in patients with severe preeclampsia, and 6.6% (1/15) in women with normal pregnancy, respectively (P =.009). The pseudocholinesterase activity was found to correlate with serum alanine aminotransferase levels (r = 0.417, P = .006) and with serum aspartate aminotransferase levels (r = 0.462, P = .002). Considering the increased prevalence of reduced pseudocholinesterase activity in patients with HELLP syndrome, the authors suggest that whenever general anesthesia is applied in these patients, the anesthesiologist should be aware that the patient may show slow metabolic degradation of choline-ester drugs.

Key Words: HELLP syndrome • pseudocholinesterase • severe preeclampsia • obstetric anesthesia.

Reproductive Sciences, Vol. 14, No. 2, 192-196 (2007)
DOI: 10.1177/1933719107299871


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?